Peritoneal ultrafiltration in patients with advanced decompensated heart failure

Gian Maria Iadarola, Paola Lusardi, Vincenzo La Milia, Gianpaolo Amici, Stefano Santarelli, Giovambattista Virga, Carlo Basile, Silvio Bertoli, Renzo Bonofiglio, Goffredo Del Rosso, Mariano Feriani, Emilio Galli, Maurizio Gallieni, Giovanni Gambaro, Massimo Sandrini, Sergio Sisca, Giovanni Cancarini

Research output: Contribution to journalArticlepeer-review

Abstract

The aim of the Best Practice guidelines on peritoneal ultrafiltration (UF) in patients with treatment-resistant advanced decompensated heart failure (TR-AHDF) is to achieve a common approach to the management of decompensated heart failure in those situations in which all conventional treatment options have been unsuccessful, and to stimulate a closer cooperation between nephrologists and cardiologists. The standardization of the case series of different centers would allow a better definition of the results published in the literature, without which they are nothing more than anecdotes. TR-AHDF is characterized by the persistence of severe symptoms even when all possible pharmacological and surgical options have been exhausted. These patients are often treated with methods that allow extracorporeal UF - slow continuous ultrafiltration (SCUF) and continuous renal replacement therapy (CRRT) - which have to be performed in hospital facilities. Peritoneal ultrafiltration (PUF) can be considered a treatment option in patients with TR - AHDF when, despite the fact that all treatment options have been used, patients meet the following criteria: • stage D decompensated heart failure (ACC/AHA classification); • INTERMACS level 4 decompensated heart failure; • INTERMACS frequent flyer profile; • chronic renal failure (estimated glomerular filtration rate 2: KDOQI classification stage 3 chronic kidney disease); • no obvious contraindications to peritoneal UF. PUF treatment modes are derived from the treatment regimens proposed by various authors to obtain systemic UF in patients with severe decompensated heart failure, using manual and automated incremental peritoneal dialysis involving various glucose concentrations in addition to the single icodextrin exchange. These guidelines also identify a minimum set of tests and procedures for the follow-up phase, to be supplemented, according to the center's resources and policy, with other tests that are less routine or more complex also from a logistic/organizational standpoint, emphasizing the need for the patient's clinical and treatment program to involve both the nephrologist and the cardiologist. The pathophysiological aspects of a deterioration in kidney function in patients with decompensated heart failure are also considered, and the results of PUF in patients with decompensated heart failure reported in the various case series are reviewed.

Original languageEnglish
JournalJournal of Nephrology
Volume26
Issue numberSUPPL.21
DOIs
Publication statusPublished - Nov 2013

Keywords

  • Advanced heart failure
  • Icodextrin
  • Incremental peritoneal dialysis
  • Peritoneal dialysis
  • Peritoneal ultrafiltration
  • Refractory heart failure

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Peritoneal ultrafiltration in patients with advanced decompensated heart failure'. Together they form a unique fingerprint.

Cite this